|
22379
|
Ammoniak
|
|
EDTA |
Dagelijks |
4 (0,2) |
–
|
32664-5
ug/dL |
1839-0
umol/L |
› |
|
22400
|
Amylase
|
|
Serum |
Dagelijks |
1 (0,1) |
B
|
1798-8
U/L |
—
|
› |
|
26910
|
Amylase
|
|
Urine |
Dagelijks |
26 (1,1) |
–
|
1799-6
U/L |
—
|
› |
|
28794
|
Amylase
|
|
Punctievocht (Ascites / Pleura / Pericard) |
Dagelijks |
|
–
|
1795-4
U/L |
—
|
› |
|
26926
|
Amylase/creatinine clear.
Panel
Amylase/creatinine klaring
|
|
Serum, Urine |
|
122 (5,1) |
–
|
—
|
—
|
› |
|
23140
|
ANA (HEp-2, 1/80)
ANA, ANF, Antinucleaire antilichamen
|
|
Serum |
Maandag t/m vrijdag |
72 (3) |
B
|
59069-5
|
—
|
› |
|
71210
|
Ananas f210 IgG
|
|
Serum |
2x per week, op Dinsdag en Vrijdag |
|
–
|
—
mgA/l |
—
|
› |
|
4390
|
Anaplasma phagocytophilum
Panel
|
|
Serum |
|
|
–
|
—
|
—
|
› |
|
23260
|
ANCA/MPO/PR3 diagnose
Panel
Anti-MPO, Anti-Myeloperoxidase, Anti-PR3
|
|
Serum |
|
65 (2,7) |
–
|
46266-3
|
—
|
› |
|
90550
|
Ander
Panel
|
|
Biopsie |
|
78 (3,2) |
–
|
—
|
—
|
› |
|
34351
|
Androstaandiolglucuronide
3 alfa-diol glucuronide, 5 alfa-androstaan-3 alfa-17 beta-diol-glucuronide, 5 alfa-androstane-3 alfa-17 beta-diol-glucuronide
|
|
Serum |
2x per week |
89 (3,7) |
–
|
1680-8
ng/mL |
15008-6
nmol/L |
› |
|
57120
|
Androsteendion
Delta-4-androsteendion
|
|
Serum |
3x per week |
145 (6) |
–
|
—
ng/dL |
14603-5
nmol/L |
› |
|
22652
|
Angiotensine conv. enzym
ACE, Kininase II
|
|
Serum |
Maandag t/m vrijdag |
22 (0,9) |
–
|
2742-5
U/L |
—
|
› |
|
22141
|
Aniongap
Panel
|
|
Serum |
|
1 (0) |
–
|
—
|
—
|
› |
|
4328
|
Anisakis (ELISA)
✉
Haringwormziekte antistoffen
|
|
Serum |
1x per 2 weken |
197 (8,2) |
–
|
—
|
—
|
› |
|
23337
|
Anti-Aquaporine-4 (1/1)
Anti-NMO (1/1)
|
|
Lumbaalvocht (CSV) |
1x per 1-2 weken |
129 (5,4) |
–
|
—
|
—
|
› |
|
23282
|
Anti-Aquaporine-4 (1/10)
Anti-NMO (1/10)
|
|
Serum |
1x per 1-2 weken |
46 (1,9) |
–
|
43638-6
|
—
|
› |
|
23338
|
Anti-Aquaporine-4 titer
|
|
Lumbaalvocht (CSV) |
|
|
–
|
—
|
—
|
› |
|
23336
|
Anti-Aquaporine-4 titer
|
|
Serum |
|
99 (4,1) |
–
|
95273-9
|
—
|
› |
|
23332
|
Anti-beta2 glycoproteïne
Panel
|
|
Serum |
|
57 (2,4) |
–
|
—
|
—
|
› |
|
23308
|
Anti-cardiolipine IgG
Anti-fosfolipiden antistoffen, Cardiolipine IgG
|
|
Serum |
Maandag t/m vrijdag |
26 (1,1) |
–
|
3181-5
GPL U/ml |
—
|
› |
|
23307
|
Anti-cardiolipine IgM
Anti-fosfolipiden antistoffen, Cardiolipine IgM
|
|
Serum |
Maandag t/m vrijdag |
26 (1,1) |
–
|
3182-3
MPL U/ml |
—
|
› |
|
23138
|
Anti-CCP
Anti-Cyclic Citrullinated Peptide, Cyclic Citrullinated Peptide Antibody, Cyclisch gecitrullineerde peptiden
|
|
Serum |
Maandag t/m vrijdag |
3 (0,1) |
–
|
53027-9
U/ml |
—
|
› |
|
24006
|
Anti-Endomysium IgA 1/10
|
|
Serum |
Tenminste 1x per week |
156 (6,5) |
–
|
46126-9
|
—
|
› |
|
24021
|
Anti-Endomysium IgG 1/10
|
|
Serum |
Tenminste 1x per week |
26 (1,1) |
–
|
39554-1
|
—
|
› |
|
1342
|
anti-factor Xa
✉
|
|
Citraat |
1x per week |
96 (4) |
–
|
3216-9
IU/ml |
—
|
› |
|
22591
|
anti-GAD
Anti Glutamic Acid Decarboxylase 65 antistoffen, GAD65 antistoffen, GADA
|
|
Serum |
1x per 1-2 weken |
175 (7,3) |
–
|
56540-8
IU/mL |
—
|
› |
|
3258
|
anti-ganglioside AS
✉
|
|
Serum |
|
667 (27,8) |
–
|
82455-7
|
—
|
› |
|
24000
|
Anti-gliadine DP IgA
Gedeamideerde gliadine IgA
|
|
Serum |
Maandag t/m vrijdag |
10 (0,4) |
–
|
63453-5
U/ml |
—
|
› |
|
24002
|
Anti-gliadine DP IgG
Gedeamideerde gliadine IgG
|
|
Serum |
Maandag t/m vrijdag |
7 (0,3) |
–
|
58710-5
U/ml |
20496-6
U/ml |
› |
|
3306
|
anti-glycine receptor As
✉
|
|
Serum |
|
319 (13,3) |
–
|
95722-5
|
—
|
› |
|
24496
|
anti-HBs na 4 weken
HBV surface antistoffen na 4 weken
|
|
Serum |
Dagelijks |
1 (0) |
B
|
—
mIU/mL |
—
|
› |
|
24499
|
anti-HBs na booster
HBV surface antistoffen na booster
|
|
Serum |
|
1 (0,1) |
B
|
—
mIU/mL |
—
|
› |
|
24506
|
anti-HBs na booster 5
|
|
Serum |
|
1 (0) |
–
|
—
mIU/mL |
—
|
› |
|
24497
|
anti-HBs voor booster
HBV surface antistoffen voor booster
|
|
Serum |
|
1 (0,1) |
B
|
—
mIU/mL |
—
|
› |
|
3314
|
Anti-histonen
✉
|
|
Serum |
|
|
–
|
17380-7
U/ml |
—
|
› |
|
2592
|
anti-IA2 antilichamen
✉
|
|
Serum |
Maandelijks |
909 (37,9) |
–
|
31209-0
U/mL |
—
|
› |
|
23206
|
Anti-intrinsic factor IgG
Anti-intrisic factor antistoffen, Intrisic factor antistoffen
|
|
Serum |
Maandag t/m vrijdag |
34 (1,4) |
–
|
56539-0
U/mL |
—
|
› |
|
3242
|
anti-MAG As
✉
Myeline geassocieerde glycoproteïne antistoffen
|
|
Serum |
|
873 (36,4) |
–
|
31023-5
|
—
|
› |
|
24611
|
Anti-Mazelen IgG
|
|
Serum |
3x per week |
58 (2,4) |
B
|
7962-4
IU/L |
7962-4
mIU/mL |
› |
|
23354
|
Anti-MOG (1/1)
Myeline oligodentrocyte glycoproteïne antistoffen (1/1)
|
|
Lumbaalvocht (CSV) |
1x per 1-2 weken |
112 (4,7) |
–
|
91543-9
|
—
|
› |
|
23304
|
Anti-MOG (1/10)
Myeline oligodentrocyte glycoproteïne antistoffen (1/10)
|
|
Serum |
1x per 1-2 weken |
46 (1,9) |
–
|
106548-1
|
—
|
› |
|
23353
|
Anti-MOG titer
|
|
Serum |
|
149 (6,2) |
–
|
84873-9
|
—
|
› |
|
23355
|
Anti-MOG titer
|
|
Lumbaalvocht (CSV) |
|
|
–
|
—
|
—
|
› |
|
25054
|
Anti-Müllerian Hormoon
|
|
Serum |
Dagelijks |
23 (1) |
B
|
38476-8
ng/mL |
—
|
› |
|
3277
|
anti-MuSK As
✉
Anti-muscle specific kinase antistoffen
|
|
Serum |
|
278 (11,6) |
–
|
94273-0
|
—
|
› |
|
3313
|
Anti-nucleosomen
✉
|
|
Serum |
|
|
–
|
53014-7
U/ml |
—
|
› |
|
24185
|
Anti-Tetanus Toxoid IgG
|
|
Serum |
1x per week |
177 (7,4) |
–
|
—
IU/mL |
—
|
› |
|
24948
|
Anti-thyroglobuline As
Anti-TG antistoffen, Colloïd antistoffen, Thyreoglobuline antistoffen
|
|
Serum |
Maandag t/m vrijdag |
5 (0,2) |
B
|
8098-6
IU/mL |
—
|
› |
|
24952
|
Anti-TPO As
|
|
Serum |
Maandag t/m vrijdag |
|
–
|
8099-4
IU/mL |
—
|
› |
